Videos / Recombinant respiratory syncytial virus pre-fusion F protein vaccine
In this Product Explainer, Infectious Disease Physician and Microbiologist Prof Paul Griffin explains the role of a recombinant respiratory syncytial virus pre-fusion F protein vaccine for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).
Additional resources
Eczema Management Practical Tips
Oral Contraception Updates
Panel Discussion on GLP1s for Chronic Kidney Disease in Type 2 Diabetes
COVID and the Heart – Short & Long-Term Impacts and Risks
expert
Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland